Literature DB >> 8406925

Biomonitoring of nickel and chromium in human pulmonary tissue.

H J Raithel1, K H Schaller, T Kraus, G Lehnert.   

Abstract

Nickel (Ni) and chromium (Cr) and some of its compounds may be able to induce cancer in the lungs as well as in the nose and paranasal sinuses after occupational exposure. Latency periods amount to 20 years and more. Therefore objective exposure data are not available in the most cases and expert evaluation of the causal connection is often difficult. Recent investigations have shown, that Ni and Cr can cumulate in human lung tissue after occupational exposure. For the evaluation of "normal" Ni- and Cr-values a total of 495 human lung tissue samples of 30 occupationally non-exposed persons were analysed by AAS including ZEEMAN-compensation after wet oxidative digestion. Additional samples of 10 deceased persons who have been occupationally exposed to nickel in previous times by nickel-refining and welding, especially flame spraying have been investigated. The median Ni- and Cr- concentrations in the lungs of the non-exposed persons ranged between 20-40 resp. 133-277 ng/g (wet weight). In nickel refinery workers Ni- concentrations were found which exceeded the normal range about 1,000. In welders, especially flame sprayers, also values more than 100 times higher could be analysed for Ni and Cr. Partially these concentrations were found years after the end of the inhalative exposure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406925     DOI: 10.1007/bf00381340

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  5 in total

1.  Investigations on the quantitative determination of nickel and chromium in human lung tissue. Industrial medical, toxicological, and occupational medical expertise aspects.

Authors:  H J Raithel; K H Schaller; A Reith; K B Svenes; H Valentin
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

2.  Analyses of chromium and nickel in human pulmonary tissue. Investigations in lung cancer patients and a control population under special consideration of medical expertise aspects.

Authors:  H J Raithel; K H Schaller; L A Akslen; A O Myking; O Mørkve; A Gulsvik
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

3.  Problems in establishing norm values for nickel and chromium concentrations in human pulmonary tissue.

Authors:  H J Raithel; G Ebner; K H Schaller; B Schellmann; H Valentin
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

4.  Determination of nickel in lung specimens of thirty-nine autopsied nickel workers.

Authors:  I Andersen; K B Svenes
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

5.  Chromium content of organs of chromate workers with lung cancer.

Authors:  R Kishi; T Tarumi; E Uchino; H Miyake
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

  5 in total
  7 in total

1.  Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells.

Authors:  Young-Ok Son; J Andrew Hitron; Xin Wang; Qingshan Chang; Jingju Pan; Zhuo Zhang; Jiankang Liu; Shuxia Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-16       Impact factor: 4.219

2.  The pro-oxidant chromium(VI) inhibits mitochondrial complex I, complex II, and aconitase in the bronchial epithelium: EPR markers for Fe-S proteins.

Authors:  Charles R Myers; William E Antholine; Judith M Myers
Journal:  Free Radic Biol Med       Date:  2010-09-27       Impact factor: 7.376

3.  Reduction of hexavalent chromium by human cytochrome b5: generation of hydroxyl radical and superoxide.

Authors:  Griselda R Borthiry; William E Antholine; B Kalyanaraman; Judith M Myers; Charles R Myers
Journal:  Free Radic Biol Med       Date:  2006-12-15       Impact factor: 7.376

4.  Reductive activation of hexavalent chromium by human lung epithelial cells: generation of Cr(V) and Cr(V)-thiol species.

Authors:  Griselda R Borthiry; William E Antholine; Judith M Myers; Charles R Myers
Journal:  J Inorg Biochem       Date:  2008-01-08       Impact factor: 4.155

5.  The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells.

Authors:  Judith M Myers; Charles R Myers
Journal:  Free Radic Biol Med       Date:  2009-08-22       Impact factor: 7.376

6.  Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients.

Authors:  Matteo Goldoni; Andrea Caglieri; Massimo Corradi; Diana Poli; Michele Rusca; Paolo Carbognani; Antonio Mutti
Journal:  Int Arch Occup Environ Health       Date:  2007-08-28       Impact factor: 3.015

7.  Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells.

Authors:  Judith M Myers; William E Antholine; Charles R Myers
Journal:  Toxicology       Date:  2008-02-02       Impact factor: 4.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.